Zydus Lifesciences Q2 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
962.7
14.00 (1.48%)
14.00 (1.48%)Volume16.80 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
964.3515.30 (1.61%)
15.30 (1.61%)Volume2.66 M
Updated: Mon 25 Nov, 2024 | 15:44:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹5,237.00 Cr.(-15.63%)
- Operating Profit₹1,182.40 Cr.(-37.57%)
- Profit After Tax₹910.90 Cr.(-35.85%)
- Operating Margin22.58%(12.13%)
Note: Comparison is on YoY basis
Quarterly - Zydus Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 5,237.00 | 5,139.60 | -% | 4,368.80 | -% |
| Selling/ General/ Admin Expenses Total | 879.20 | 730.40 | -% | 752.90 | -% |
| Depreciation/ Amortization | 233.60 | 179.80 | -% | 184.20 | -% |
| Other Operating Expenses Total | 1,470.40 | 1,202.40 | -% | 1,078.20 | -% |
| Total Operating Expense | 4,054.60 | 3,801.20 | -% | 3,489.10 | -% |
| Operating Income | 1,182.40 | 1,338.40 | -% | 879.70 | -% |
| Net Income Before Taxes | 1,270.90 | 1,329.20 | -% | 1,007.20 | -% |
| Net Income | 911.20 | 1,086.90 | -% | 800.70 | -% |
| Diluted Normalized EPS | 9.06 | 10.87 | -% | 7.92 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST